Companies / BOC Sciences / Enlimomab
BOC Sciences

Enlimomab | BOC Sciences

Enlimomab is a mouse monoclonal antibody against ICAM-1 and has been observed to inhibit neutrophil adhesion to brain endothelium in vitro. Enlimomab is proved to be beneficial in reducing disease activity in a subset of patients with rheumatoid arthritis.

Reviews


No reviews yet

ABOUT THE COMPANY

BOC Sciences specializes in small molecule synthesis, biosynthesis, purification, and characterization. It provides a wide range of research chemicals and biochemicals, including inhibitors, building blocks, carbohydrates, nucleosides, nucleotides, GMP Products, impurities and metabolites, APIs, natural compounds, ADCs, stem cell molecules and chiral compounds.